Health CanadaGeneral Alert
Archived - Infection-related deaths were reported with the use of MabCampath (alemtuzumab) following initial combination therapy with anti-leukemia drugs which also suppress the body's immune response - For the Public
Published: November 21, 2008Recall ID: 22965Category: generalCountry: Canada
Safety AlertHealth CanadaCanada
CanadaArchived - Infection-related deaths were reported with the use of MabCampath (alemtuzumab) following initial combination therapy with anti-leukemia drugs which also suppress the body's immune response - For the Public
Recalling Firm: Marketed health products
Product Description & Identification
Archived - Infection-related deaths were reported with the use of MabCampath (alemtuzumab) following initial combination therapy with anti-leukemia drugs which also suppress the body's immune response - For the Public
Additional Source Details
| Field | Value |
|---|---|
| N I D | 22965 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/archived-infection-related-deaths-were-reported-use-mabcampath-alemtuzumab-following |
| Title | Archived - Infection-related deaths were reported with the use of MabCampath (alemtuzumab) following initial combination therapy with anti-leukemia drugs which also suppress the body's immune response - For the Public |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2008-11-21 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Archived - Infection-related deaths were reported with the use of MabCampath (alemtuzumab) following initial combination therapy with anti-leukemia drugs which also suppress the body's immune response - For the Public Check if your household is affected: https://therecallfile.com/recalls/archived-infection-related-deaths-were-reported-with-the-use-of-mabcam/CANADA-22965
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Featured on Product Hunt
Help support our public safety mission and check out our community launch.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordArchived - Infection-related deaths were reported with the use of MabCampath (alemtuzumab) following initial combination therapy with anti-leukemia drugs which also suppress the body's immune response - For the Public
Related Recalls
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018088 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018088 -
Tires
—TC
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018288 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018288 -
Airbag
—TC
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018409 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018409 -
Airbag
—TC